New insights into p53 signaling and cancer cell response to DNA damage: implications for cancer therapy
R Mirzayans, B Andrais, A Scott… - BioMed Research …, 2012 - Wiley Online Library
Activation of the p53 signaling pathway by DNA‐damaging agents was originally proposed
to result either in cell cycle checkpoint activation to promote survival or in apoptotic cell …
to result either in cell cycle checkpoint activation to promote survival or in apoptotic cell …
Current concepts in clinical radiation oncology
M Orth, K Lauber, M Niyazi, AA Friedl, M Li… - Radiation and …, 2014 - Springer
Based on its potent capacity to induce tumor cell death and to abrogate clonogenic survival,
radiotherapy is a key part of multimodal cancer treatment approaches. Numerous clinical …
radiotherapy is a key part of multimodal cancer treatment approaches. Numerous clinical …
Dying cell clearance and its impact on the outcome of tumor radiotherapy
K Lauber, A Ernst, M Orth, M Herrmann… - Frontiers in oncology, 2012 - frontiersin.org
The induction of tumor cell death is one of the major goals of radiotherapy and has been
considered to be the central determinant of its therapeutic outcome for a long time. However …
considered to be the central determinant of its therapeutic outcome for a long time. However …
[HTML][HTML] Chk1 suppresses a caspase-2 apoptotic response to DNA damage that bypasses p53, Bcl-2, and caspase-3
S Sidi, T Sanda, RD Kennedy, AT Hagen, CA Jette… - Cell, 2008 - cell.com
Evasion of DNA damage-induced cell death, via mutation of the p53 tumor suppressor or
overexpression of prosurvival Bcl-2 family proteins, is a key step toward malignant …
overexpression of prosurvival Bcl-2 family proteins, is a key step toward malignant …
SIRT1 in the cardiomyocyte counteracts doxorubicin-induced cardiotoxicity via regulating histone H2AX
A Kuno, R Hosoda, M Tsukamoto, T Sato… - Cardiovascular …, 2022 - academic.oup.com
Aims Cardiotoxicity by doxorubicin predicts worse prognosis of patients. Accumulation of
damaged DNA has been implicated in doxorubicin-induced cardiotoxicity. SIRT1, an NAD+ …
damaged DNA has been implicated in doxorubicin-induced cardiotoxicity. SIRT1, an NAD+ …
Dual-function nanosystem for synergetic cancer chemo-/radiotherapy through ROS-mediated signaling pathways
Radioresistance and limitation of irradiative dosage usually lead to failure in depletion of
hypoxic tumors. Herein we developed multifunctional mesoporous silica nanoparticles …
hypoxic tumors. Herein we developed multifunctional mesoporous silica nanoparticles …
Mechanisms of radiation toxicity in transformed and non-transformed cells
RAM Panganiban, AL Snow, RM Day - International journal of molecular …, 2013 - mdpi.com
Radiation damage to biological systems is determined by the type of radiation, the total
dosage of exposure, the dose rate, and the region of the body exposed. Three modes of cell …
dosage of exposure, the dose rate, and the region of the body exposed. Three modes of cell …
Radiation exposure induces inflammasome pathway activation in immune cells
VM Stoecklein, A Osuka, S Ishikawa… - The Journal of …, 2015 - journals.aai.org
Radiation exposure induces cell and tissue damage, causing local and systemic
inflammatory responses. Because the inflammasome pathway is triggered by cell death and …
inflammatory responses. Because the inflammasome pathway is triggered by cell death and …
P53 status, and G2/M cell cycle arrest, are determining factors in cell-death induction mediated by ELF-EMF in glioblastoma
R Mehdizadeh, A Madjid Ansari, F Forouzesh… - Scientific reports, 2023 - nature.com
The average survival of patients with glioblastoma is 12–15 months. Therefore, finding a
new treatment method is important, especially in cases that show resistance to treatment …
new treatment method is important, especially in cases that show resistance to treatment …
Chlorotoxin modified morusin–PLGA nanoparticles for targeted glioblastoma therapy
S Agarwal, MS Mohamed, T Mizuki… - Journal of Materials …, 2019 - pubs.rsc.org
Malignant brain tumors remain a major cause of concern and mortality as successful
treatment is hindered due to the poor transport and low penetration of chemotherapeutics …
treatment is hindered due to the poor transport and low penetration of chemotherapeutics …